Sentence examples for trial growth from inspiring English sources
Previous studies comparing expectant management and induction of labour in high risk pregnancies showed a discrepancy between observational PRN data and data from randomised trials (Digitat trial (growth retardation) and Hypitat trial (hypertension at term)) [ 32, 33].
Again, if the Boltzmann factor total is below the threshold (set at 1 × 10−6), we categorize the additions to be of high energy and create 32 new trial growths.
The aim of our study was to clarify the motives of adolescents and their parents when choosing to participate in a growth-enhancing trial combining growth hormone and puberty-delaying hormone treatment.
For the inducer trial, the growth culture was adjusted to 37°C and then induced with 0.1-0.3 0.1-0.3L-arabinose.
After an 8-week feeding trial, the growth performance, serum osmotic pressure, gill ATPase activity and tissue mineralization of Ca and P of shrimp were significantly negatively affected by the replacement of fishmeal with soybean meal.
The objective of this analysis was to identify distinct patterns of placebo response trajectories that could capture individual variability in the time course of change during a 1-year trial using growth mixture latent class analyses.
In trial 1 growth traits from 26 to 48 days of age and the coefficient of total tract apparent digestibility (CTTAD) of dietary components at 36 and 48 days of age were assessed.
Statistical analysis for solid leaching rates showed that there was no significant difference (P > 0.05) in percentage of remaining dry weight between the dietary protein levels in trial 2. Growth performances of opihi that were fed at various carbohydrate levels are shown in Table 4.
The associated marker alleles with five functional traits at two sampling times by Q + K model in greenhouse trial and growth chambers trial, respectively (P < 0.01).
97 and 67 marker alleles associated with heat tolerance-related traits were identified in greenhouse trial and growth chamber trial (P < 0.01) using mix linear model, respectively.
Morbidity and mortality were recording in all three groups during the trial and growth performance parameter (average daily gain (ADG)) calculated at the end.
